Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis | SpringerLink
Frontiers | Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke | Neurology
Mechanism of action of S1P and fingolimod-P. (a) In physiological... | Download Scientific Diagram
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
Mechanism of action of Fingolimod | Download Scientific Diagram
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy - Journal of the Neurological Sciences
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
Mechanism of action of Fingolimod | Download Scientific Diagram
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system - Brinkmann - 2009 - British Journal of Pharmacology - Wiley Online Library
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis | Semantic Scholar
Frontiers | Fingolimod for the treatment of neurological diseases—state of play and future perspectives | Cellular Neuroscience
Fingolimod is a potential novel therapy for multiple sclerosis | Nature Reviews Neurology
Emerging multiple sclerosis oral therapies | Semantic Scholar
Oral Therapies in MS: Changing the Care Paradigm (Transcript)
More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis
Fingolimod
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis: Molecular Therapy
Emerging multiple sclerosis oral therapies | Neurology
Gilenya (fingolimod) - Rare Disease Advisor
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation | Journal of Neuroinflammation | Full Text
Fingolimod - Novel Therapy for Multiple Sclerosis - Clinical Trials Arena
